Strategy

US Presidential hopefuls set their sights on pharma patents

With several leading Democratic candidates threatening to circumvent pharma IP, next year’s election could prove pivotal for right owners

US Presidential hopefuls set their sights on pharma patents
20 Nov 2019

More Data Business Congress speakers revealed

Microsoft and Intel provide the keynotes; with senior leaders from a wide range of companies confirmed to participate in groundbreaking event

19 Nov 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

Latest

View all
19 Nov 2019

Second listing sees Alibaba on firmer IP footing

The e-commerce giant prices its Hong Kong offering this week. Five years after its NYSE debut, it has a more formidable patent portfolio and new IP-based alliances Read more

18 Nov 2019

South Africa's top court issues first patent decision but fails to clarify infringement defence uncertainties

The country’s Constitutional Court, which split down the middle, refused to grant an appeal to challenge a Merck patent on new grounds Read more

18 Nov 2019

TCL unit wins injunction in domestic panel fight

Shenzhen ruling comes just seven months after China Star Optoelectronics went after a Chongqing-based rival for infringement Read more

15 Nov 2019

Another big LG assertion could signal a strategy shift

The Korean electronics giant has accused TCL of infringement in Germany, in another lawsuit targeting a Chinese rival Read more

News

View all
8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

6 Nov 2019

New report reveals why SMEs want patents and the opportunities they bring

Study released by the European Patent Office sheds light on the growing sophistication of smaller businesses seeking protection for their inventions Read more

31 Oct 2019

IAM honours Asia’s IP leaders

The winners of our annual Asia IP Elite awards for the teams, deal and individual of the year were revealed before a sold-out crowd at IPBC Asia 2019 Read more

30 Oct 2019

IPBC Asia comes to a brilliant end in Tokyo

A hugely successful conference that attracted a record attendance is now over after a day of talk about 5G licensing, the Chinese and Japanese IP landscapes, data, litigation and a whole lot more Read more

Analysis

View all
14 Nov 2019

Legal landscape more rational now but will shift back, says Facebook IP supremo

Get your deals done now before the market begins to rebalance in favour of patent owners, Allen Lo advises licensees while speaking on panel at the annual IP Dealmakers conference Read more

14 Nov 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms Read more

13 Nov 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options Read more

12 Nov 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016 Read more

Insights

View all
30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

1 Feb 2018

Rollercoaster ride for SEP owners continues through 2017

SEP owners had much to celebrate in 2017 but a major decision from a US court meant that the year ended with a familiar amount of uncertainty Read more

Find an expert